Healthcare Industry News: HSMN NewsFeed
News Release - October 2, 2017
Elekta and The Alliance for Cancer Care Partner to Bring Leading-edge Radiation Therapy and Radiosurgery Solutions to PatientsThe Alliance for Cancer Care converts all oncology treatment devices and software to Elekta products, improving and standardizing care across its multiple sites
STOCKHOLM, Oct. 2, 2017 -- (Healthcare Sales & Marketing Network) -- Elekta (EKTA-B.ST) today announced that the Alliance for Cancer Care (The Alliance) is adopting Elekta products and services as the complete solution for its radiation oncology needs. With this adoption, Elekta hardware and software will replace all other radiation therapy products and services at The Alliance's seven radiation therapy facilities.
Established in 2015, The Alliance brings together the best caregivers, resources and technology from Providence Health Care, Kootenai Health and Cancer Care Northwest. The Alliance's mission and vision is to provide world-class and comprehensive cancer care to patients in Spokane (Washington), Coeur d'Alene (Idaho) and throughout the Inland Pacific Northwest.
"After evaluating multiple radiation oncology hardware and software options, it became clear that Elekta shares our commitment to making leading-edge technology safe, effective and broadly available to individuals with cancer and brain disease," said Aaron Wagner, MD, Director of Radiation Oncology, Medical Director of the Alliance for Cancer Care, Cancer Care Northwest. "Through their flexibility in designing a complete hardware and software package customized to the needs of our patients and facilities, Elekta demonstrated their desire to be our long-term partner in making the most advanced radiation treatment systems available to our patients. Their customer-centric training and support services have enabled a smooth transition to Elekta products."
With its transition to Elekta products and services, The Alliance can now offer its patients the most advanced technologies across the spectrum of radiation therapy, including stereotactic radiosurgery, stereotactic body radiation therapy and brachytherapy. The suite of Elekta solutions being implemented at The Alliance's sites enables more precise treatments through the use of highest-quality imaging that can account for potential motion of the patient or the tumor during treatment. Increased precision allows for the use of higher radiation doses while protecting normal tissue, reducing treatment times to just a few minutes per session, which is significantly less time than needed for conventional radiation therapy devices. Importantly, all of Elekta's radiotherapy devices are equipped with tools that allow treatment to be tailored to the specific types of cancers, enabling personalized radiation therapy.
The combined benefits that Elekta's devices and software solutions provide can improve patients' experiences and outcomes during and after treatment. "Waking up with an egg-sized lump on my breast was shocking; being diagnosed later that day with stage 3 breast cancer transformed my shock into terror," said Kelly Buche, who underwent chemotherapy, surgery and radiation therapy at The Alliance. "Throughout my treatment, The Alliance staff was like family, acknowledging how difficult the cancer journey would be and ensuring me that they would be with me every step of the way. Even when I had to come in daily for six weeks during my radiation therapy, they had a highly efficient and supportive process that helped to minimize my time at the hospital. Their approach to addressing the physical, medical, emotional, social and financial needs of their patients is a powerful weapon in the fight against cancer, and I am grateful to have them on my side."
The Alliance is also implementing Elekta's MOSAIQ® Oncology Analytics (MOA), a powerful software solution that seeks to provide oncology centers with a comprehensive picture of the data that drives key decisions around cost efficiencies and improvements in the quality of care. MOA ensures data integrity and security, provides real-time insight into patient populations and community demographics, and generates actionable information to help improve patient care by reducing waiting times, eliminating bottlenecks and improving workflows. Together, these features are expected to help The Alliance optimize operations and reduce the cost of delivering high-quality cancer care while addressing key challenges in today's health care economic environment.
"We do not innovate in a vacuum – Elekta collaborates closely with our customers to create the solutions they need to treat patients more effectively, precisely and efficiently. Our goal is to help them improve, prolong and save the lives of as many patients as possible," said Peter Gaccione, EVP Region North America at Elekta. "The Alliance's commitment to providing patients with world-class care close to home is entirely aligned with the ideals and objectives of Elekta. We look forward to a long and productive relationship that meets The Alliance's clinical and operational needs."
For further information, please contact:
Gert van Santen
Group Vice President Corporate Communications, Elekta AB
Time zone: CET: Central European Time
Global Public Relations Manager, Elekta
Time zone: ET: Eastern Time
Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.
Related News ItemsElekta Introduces New Commercial Name for MEG Business and Reveals New System for Studying Brain Activity at 2017 American Epilepsy Society Meeting
Elekta and Brainlab Collaborate to Streamline Treatment Workflows for Stereotactic Radiation Therapy
Elekta MR-linac Consortium Brings Founding Members Together With Clinicians From Five New Centers to Highlight Progress